Attention Deficit Hyperactivity Disorder (ADHD) Market is expected to reach US$ 27.04 billion by 2033 | Major players - Pfizer Inc., Novartis AG, Eli Lilly and Company, Lupin.

Market Size and Growth:

The Attention Deficit Hyperactivity Disorder (ADHD) Market size reached US$ 16.23 billion in 2024 and is expected to reach US$ 27.04 billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.

The Attention Deficit Hyperactivity Disorder (ADHD) Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/attention-deficit-hyperactivity-disorder-adhd-market?sz

The Attention Deficit Hyperactivity Disorder (ADHD) Market encompasses the global demand, development, and commercialization of treatments, therapies, and diagnostic solutions for ADHD. It includes prescription medications, behavioral therapies, digital therapeutics, and supportive interventions aimed at managing symptoms such as inattention, hyperactivity, and impulsivity. Market growth is driven by rising diagnosis rates, awareness, and innovation in treatment approaches.

Recent Key Developments of United States:

✅ December 2025: Washington University School of Medicine published research revealing that stimulant ADHD medications function differently than previously understood, not primarily through attention circuitry, potentially influencing future treatment strategies.

✅ December 2025: Granules India received USFDA tentative approval for its generic ADHD medication, targeting a $172 million U.S. market opportunity and enhancing access to affordable treatments for the neurodevelopmental disorder.

✅ November 2025: Otsuka Pharmaceutical submitted a New Drug Application to the U.S. FDA for centanafadine, a novel triple reuptake inhibitor for treating ADHD in children, adolescents, and adults, based on positive Phase 3 trial results showing significant symptom improvements.​​​

Recent Key Developments of Japan:

✅ November 2025: AI-driven diagnostic tools gained prominence in Japan's ADHD market, improving early detection accuracy and enabling personalized treatments through analysis of behavioral, neuroimaging, and genetic data.​

✅ November 2025: Personalized AI-powered treatment solutions emerged, reshaping the market by customizing medication, therapies, and digital interventions based on individual data, supported by Japan's precision medicine focus.​

✅ September 2025: Digital therapeutics for children with ADHD expanded rapidly, featuring AI cognitive training and remote platforms, driven by regulatory support and a 5-7% prevalence rate among Japanese children.​

List of the Key Players in the Attention Deficit Hyperactivity Disorder (ADHD) Market:

Pfizer Inc.
Takeda Pharmaceutical Company Limited
Novartis AG
Eli Lilly and Company
Lupin
Mallinckrodt
Hisamitsu Pharmaceutical Co., Inc.
Camber Pharmaceuticals, Inc.
Collegium Pharmaceutical, Inc.
Supernus Pharmaceuticals, Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/attention-deficit-hyperactivity-disorder-adhd-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market:

By Type: Predominantly Inattentive Presentation, Predominantly Hyperactive/Impulsive Presentation, Combined Presentation.

By Drug Type: Stimulants, Non-stimulants.

By Age Group: Pediatric, Adults, Geriatrics.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=attention-deficit-hyperactivity-disorder-adhd-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Attention Deficit Hyperactivity Disorder (ADHD) market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Attention Deficit Hyperactivity Disorder (ADHD) Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Attention Deficit Hyperactivity Disorder (ADHD) market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Attention Deficit Hyperactivity Disorder (ADHD) Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Attention Deficit Hyperactivity Disorder (ADHD) Market in 2025?
◆ What is the projected growth rate of the Attention Deficit Hyperactivity Disorder (ADHD) Market through 2033?
◆ Who are the key players in the Attention Deficit Hyperactivity Disorder (ADHD) Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.